title: Disappearance of minimal residual disease after the early withdrawal of immunosuppressants in a patient with juvenile myelomonocytic leukemia.
authors.forename: Ryu
authors.initials: R
authors.lastname: Yanagisawa
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Matsuda
authors.forename: Kazuo
authors.initials: K
authors.lastname: Sakashita
authors.forename: Yozo
authors.initials: Y
authors.lastname: Nakazawa
authors.forename: Miyuki
authors.initials: M
authors.lastname: Tanaka
authors.forename: Shoji
authors.initials: S
authors.lastname: Saito
authors.forename: Kentaro
authors.initials: K
authors.lastname: Yoshikawa
authors.forename: Takehiko
authors.initials: T
authors.lastname: Kamijo
authors.forename: Masaaki
authors.initials: M
authors.lastname: Shiohara
authors.forename: Kenichi
authors.initials: K
authors.lastname: Koike
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000378:metabolism* / Q000627:therapeutic use*; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D054429:Leukemia, Myelomonocytic, Juvenile / Q000235:genetics / Q000628:therapy*; D018365:Neoplasm, Residual / Q000235:genetics / Q000517:prevention & control*; D012074:Remission Induction
chemical_list: D007166:Immunosuppressive Agents